Susi Roger E. sold $85K of IRMD (indirect holdings)
Susi Roger E. (CEO, President, Chairman) sold 924 indirectly-held shares of IRADIMED CORP (IRMD) at $91.91 on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Traders may briefly reassess sentiment/positioning, but the 10b5-1 designation generally lowers the probability of a new negative fundamental catalyst.
Market read
A disclosed insider sale can move microstructure/attention, but the pre-arranged nature makes it more of a sentiment datapoint than a catalyst.
What to watch
Magnitude is modest relative to typical insider holdings; without follow-on buys/sells or changes in plan parameters, signal quality is limited.
Background
SEC Form 4 reports an officer/director/10% owner transaction for IRMD; the sale is marked as open-market and pre-arranged under Rule 10b5-1.
Ticker impact
IRMD CEO/President/Chairman Susi Roger sold $84,924 of IRMD shares via an open-market transaction under a 10b5-1 plan.
Limited, mostly sentiment/technical impact; any move likely fades unless accompanied by other catalysts.
The filing is a routine insider transaction with a pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.
Market effects
No direct sector read-through; this is company-specific insider disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.
Key entities
- issuerIRADIMED CORP
Company whose shares were sold by an insider (CEO/President/Chairman) under a 10b5-1 plan.
- insiderSusi Roger E.
CEO/President/Chairman and 10% owner who sold 924 shares at $91.91 on 2026-06-01.
